
Data Residency for Pharma: Clinical Trials, Patient Data, and the Sovereignty Question
Why Pharma Has the Hardest Residency Problem Of every industry with a data-residency posture to defend, pharmaceutical …

Why Pharma Has the Hardest Residency Problem Of every industry with a data-residency posture to defend, pharmaceutical …

Sourcing starts with a risk register now For a decade the infrastructure question had one default answer: put it in the …

The tool call is where the agent meets reality A model that only writes text cannot do much harm or much good. The …

The Phrase That Stopped Being Useful For a long time, “EU-hosted” or “data stays in the EU” was …

Swapping the model is the cheap part We made the case last week that a model you depend on can vanish on a timeline you …

The agent reads the manual, and the manual can lie When an agent connects to a tool, it does not get a function …